Redefining Postpartum Depression Treatment: The Clinical Potential of Zuranolone

被引：2
|
作者：
Nashwan, Abdulqadir J. [1 ,2 ]
Rehan, Syeda Tayyaba [3 ]
Imran, Laiba [3 ]
Abbas, Samina Ghulam [3 ]
Khan, Sara [4 ]
机构：
[1] Qatar Univ, Coll Hlth Sci, Dept Publ Hlth, QU Hlth, Doha, Qatar
[2] Hamad Med Corp, Doha, Qatar
[3] Dow Univ Hlth Sci, Karachi 74200, Pakistan
[4] Bahria Univ, Inst Profess Psychol, Karachi 75260, Pakistan
来源：
ASIAN JOURNAL OF PSYCHIATRY | 2024年 / 91卷
关键词：
D O I：
10.1016/j.ajp.2023.103849
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Zuranolone for postpartum depression: A systematic review and meta-analysis of two RCTs
    Oliveira, J. Almeida
    Eskandar, K.
    Freitas, M. A. Araujo
    Philip, C. E.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2024, 131 : 8 - 8
  • [22] The cost-effectiveness of zuranolone versus selective serotonin reuptake inhibitors for the treatment of postpartum depression in the United States
    O'Callaghan, Lasair
    Chertavian, Elizabeth
    Johnson, Scott J.
    Ferries, Erin
    Deligiannidis, Kristina M.
    JOURNAL OF MEDICAL ECONOMICS, 2024, 27 (01) : 492 - 505
  • [23] #Zuranolone: How TikTokers Perceive the First Available Oral Medication for Postpartum Depression
    Jacobsohn, Tamar
    Idoko, Joseph
    Drohan, Lilly
    Kinzler, Wendy L.
    Chavez, Martin R.
    Rekawek, Patricia
    ARCHIVES OF WOMENS MENTAL HEALTH, 2025,
  • [24] Safety and Tolerability Profile of Zuranolone From the LANDSCAPE (Major Depressive Disorder) and NEST (Postpartum Depression) Clinical Development Programs
    Deligiannidis, Kristina
    Clayton, Anita
    Lasser, Robert
    Brown, Colville
    Hughes, Richard
    Rana, Nilanjana
    Kotecha, Mona
    Doherty, James
    BIOLOGICAL PSYCHIATRY, 2022, 91 (09) : S200 - S200
  • [25] Zuranolone for postpartum depression: a systematic review and meta-analysis of two randomized studies
    Oliveira, Juliana Almeida
    Eskandar, Karine
    Freitas, Marcos Aurelio Araujo
    Philip, Chris Elizabeth
    REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA, 2024, 46
  • [26] Ketamine as potential treatment for postpartum depression: A narrative review
    Chen-Li, David
    Lui, Leanna M. W.
    Rosenblat, Joshua D.
    Lipsitz, Orly
    Teopiz, Kayla M.
    Ho, Roger
    Vinberg, Maj
    Golts, Marina
    Jawad, Muhammad Youshay
    Lee, Yena
    Nasri, Flora
    Gill, Hartej
    McIntyre, Roger S.
    ANNALS OF CLINICAL PSYCHIATRY, 2022, 34 (04) : 264 - 274
  • [27] FDA-Approved Zuranolone: First Oral Treatment for Postpartum Depression, Ushering in a New Era of Hope; A Narrative Review
    Haris, Muhammad
    Mukhtar, Sameen
    Mohiuddin, Mubashir
    Amir, Suhaina
    Laique, Fatima
    Azam, Muhammad Mazhar
    Giri, Bibek
    HEALTH SCIENCE REPORTS, 2025, 8 (03)
  • [28] Treatment of postpartum depression: clinical, psychological and pharmacological options
    Fitelson, Elizabeth
    Kim, Sarah
    Baker, Allison Scott
    Leight, Kristin
    INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2011, 3 : 1 - 14
  • [29] Rapid improvements in MADRS with zuranolone in major depressive disorder and postpartum depression: results from the LANDSCAPE/NEST clinical development programmes
    Clayton, A. H.
    Deligiannidis, K. M.
    Ramos-Quiroga, J. A.
    Lasser, R.
    Sankoh, A. J.
    Leclair, B.
    Kotecha, M.
    Doherty, J.
    EUROPEAN PSYCHIATRY, 2023, 66 : S93 - S94
  • [30] Clinical Global Impression Scores and Number Needed to Treat Outcomes in Patients With Postpartum Depression Treated With the Oral Neuroactive Steroid Zuranolone
    Deligiannidis, Kristina
    Werneburg, Brian
    Huang, Ming-Yi
    Suthoff, Ellison
    Lasser, Robert
    Gunduz-Bruce, Handan
    Acaster, Sarah
    Fridman, Moshe
    Bonthapally, Vijayveer
    Kanes, Stephen J.
    NEUROPSYCHOPHARMACOLOGY, 2020, 45 (SUPPL 1) : 323 - 324
12345